Nuage
Barcelona, ES · Founded 2021 · 23 employees on LinkedIn · 5 known investors
Find your way into Nuage
Nuage Therapeutics develops drug discovery technologies for disordered proteins, focusing on precision treatments for aggressive cancers with limited therapeutic options. The company targets disease-causing protein targets rooted in human biology.
Founders & leadership
Nuage was founded in 2021 by Mateusz Biesaga and Xavier Salvatella.
Investors · 5
Also in the syndicate · 2
AsabysleadInnvierte
Funding
SEC filings, press & company announcements- Undisclosed amountSeedJun 2023
Asabys (lead), Sofinnova Partners (lead), BStartup, Innvierte
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nuage do?
- Nuage Therapeutics develops drug discovery technologies for disordered proteins, focusing on precision treatments for aggressive cancers with limited therapeutic options. The company targets disease-causing protein targets rooted in human biology.
- Who founded Nuage?
- Nuage was founded by Mateusz Biesaga, Xavier Salvatella in 2021.
- Who are Nuage's investors?
- Nuage's investors include Sofinnova Partners, Asabys Partners, BStartup.
- Where is Nuage headquartered?
- Nuage is headquartered in Barcelona, ES.





